Party drug tested as potential treatment for Schizophrenia's social isolation
NCT ID NCT05770375
Summary
This early-stage study is checking if MDMA (commonly known as ecstasy) is safe for people with schizophrenia. It aims to see if low doses worsen psychotic symptoms like hallucinations or delusions. The goal is to eventually use the drug's known social-bonding effects to treat severe social withdrawal, a symptom not helped by current medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCLA
RECRUITINGLos Angeles, California, 90025, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.